Mary Hall
Analyst · CJS Securities. Please proceed with your question
Thank you Mike and good morning all. Before I begin, let me remind you that comments made during this call include forward-looking statements which are based on current expectations, estimates, projections and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially. For a discussion of these risks please review the cautionary statements regarding forward-looking statements included in our earnings release and in our 2018 Form 10-K filed with the SEC. These are available on our website. Please also note that updated risk factors will be included in our 2019 form 10-K which we will file before the extension deadline of March 17. As we disclosed in our press release furnished last night and the subsequent form 12B 25 of filing submitted to the SEC the company is filed for the 15 calendar day extension permitted by the SEC to allow its time to complete our year-end procedures and file our annual report on Form 10-K, which we will do no later than March 17. Therefore, all 2019 numbers we are presenting are preliminary, unaudited and subject to change as the number of regular audit and control procedures remain open. That said management believes that the financial statements included in our press release and the results discussed during this call will not change materially if at all when our Form 10-K is filed. In our press release and in this presentation we have provided certain information including non-GAAP earnings per diluted share, non-GAAP operating earnings and adjusted EBITDA as well as certain pro forma items in an effort to provide shareholders with better visibility into the company's core operations excluding certain items which we believe do not reflect our core operating performance. Reconciliations are provided in charts 15 to 24 of this investor deck and some are in the press release as well. We followed a similar review format for this deck as the one we used for our Q3 call where our comparison periods show actual and non-GAAP results and also pro forma sales and adjusted EBITDA as if we had been combined with Houghton throughout the periods presented. For this deck we have those views for both Q4 and full-year. Please see slide 6 and 7 as I begin the review of Q4 which includes Houghton as the combination was completed August 1 of last year. As Mike discussed and similar to our discussion in Q3, we continue to face strong headwinds from global automotive and general industrial weakness as well as a stronger U.S. dollar. So while our reported net sales are up Q4 versus Q4 last year this is due to the inclusion of Houghton and Norman Hay, excluding them net sales declined 10% due primarily to lower volumes of 9% and negative effects impact of 1%. On a pro forma basis as if Houghton was also in Q4 of 2018 net sales were down 2%, which also reflects the impacts from lower volumes and negative effects partially offset by the acquisition of Norman Hay. For the full year as shown on slides 8 and 9, we see a similar story with reported net sales increasing due to Houghton in Norman Hay but excluding them sales are down 6% due to lower volumes of 3% and a negative effects impact of 3% as well due primarily to a weaker Euro versus the dollar. On a pro forma basis sales are also down 6% due to similar impacts from volume and foreign exchange. Gross margin of 34.8% for Q4 reflects $0.5 million of accelerated depreciation and a $1.5 million inventory adjustment related to purchase accounting for Norman Hay. Excluding these items our gross margin would have been about 35.3% versus 35.4% last year. On a full-year basis gross margin was 34.6% including similar purchase accounting adjustments for both Norman Hay and Houghton. Excluding these items our gross margin was about 35.7% versus 36% last year. This is in line with our expectations and prior guidance reflecting the somewhat lower gross margins in the legacy housing business due in part to the accounting treatment for FLUIDCARE, the chemical management business as we discussed in Q3. Please refer now to slide 10 for a snapshot of certain key financial measures. Here you can see that our reported operating income of $20.3 million is up slightly compared to Q4 last year but on a non-GAAP basis Q4 operating income increased to $37.6 million compared to $24.3 million last year. Full year non-GAAP operating income increased to $121.9 million versus $104.4 million last year. Our operating margins in Q4 and for the full year declined driven primarily by the additional depreciation and amortization acquired with Houghton and Norman Hay on the decreases in sales. Our reported effective tax rate with the benefit of 18.2% in Q4 of ‘19 versus an expense of 59.8% in Q4 of ‘18. This current quarter's rate includes a one-time benefit from transferring certain intangible assets between non-U.S. subsidiaries and the prior year's rate reflects additional one-time expense related to U.S. tax reform. Excluding these items and various other acquisition related and non-core items, our Q4 ETRs would have been approximately 24% and 17% respectively. For the full year, we estimate that our effective tax rate excluding non-core and one-time items would have been approximately 22% in both periods in line with our guidance of 22% to 24% which we updated in Q3. Our non-GAAP EPS of $1.34 for Q4 and $5.83 for the full-year declined compared to a $1.54 and $6.17 last year primarily as a result of the additional 4.3 million shares issued at close of the combination. On slide 11, we show the trend in our pro forma adjusted EBITDA. While our $234 million of adjusted EBITDA declined slightly from $236 million in 2018, it exceeded our guidance in October. In fact our adjusted EBITDA margins improved for both the quarter and the full year. Our pro forma adjusted EBITDA margin for Q4 15.5% was up versus 15% last year. On a full-year basis our adjusted EBITDA margin increased approximately 1% to 15% versus 14% last year. The improved margins are primarily due to the inclusion of Norman Hay and the initial cost savings benefits we have realized from the combination. On slide 12, we provide an update on our leverage and liquidity. As noted, we finished the year with net debt to adjusted EBITDA of 3.47 times, up only 0.05 times since the combination closed despite significant cash outlays in Q4, which included the acquisition of Norman Hay for approximately $95 million, CapEx of about $5 million and dividends paid of approximately $7 million. This reflects our good operating cash flow in Q4, which also allowed us to end the year with cash and cash equivalents of $124 million. Our cash balances combined with undrawn portion of our revolving credit facility of about $221 million provide ample liquidity to the company. Our cost of debt in Q4 was approximately 3.1% and about 2.9% at year-end reflecting the declining interest rates. In Q4 we fixed about 20 % of the interest cost on our debt at approximately 3.1% through interest rate swaps and we continue to focus on managing our balance sheet and debt prudently. We affirm our commitment to reducing leverage to less than 2.5 times within two years post close of the combination and currently expect our leverage ratio to be at or below 3 times by the end of 2020. In summary, Quaker Houghton continues to deliver on its commitments despite the very challenging market conditions we faced in 2019. As we head into 2020 the crystal ball is murky reflecting a volatile and unpredictable global environment particularly with the unique challenges posed by the Corona virus outbreak. However, we focus on what we can control. Our integration, execution and synergy capture are on track and in fact a bit ahead of schedule and we are confident in our ability to continue to drive market share gains. Specifically we currently estimate that we will realize total integration cost synergies of approximately $35 million in 2020, that our gross margin will be in the 36 % area for the full year, that our full-year effective tax rate will be in the range of 22% to 24 %. We also continue to estimate that our one-time costs to achieve the total $60 million plus of integration cost synergies will be approximately 1 time the synergies realized. So when we put it all together even with a $16 million negative impact from the Corona virus and the 737 Max issues, we believe we will show significant growth in our adjusted EBITDA as we expect to achieve approximately $264 million or more in 2020; a 13% increase compared to $234 million in 2019 and we expect to reduce our leverage to 3 times or less by year-end as I mentioned. As we discussed at our Investor Day in December, we believe Quaker Houghton is well-positioned for growth and we are focused on delivering long term value for our shareholders. Thank you for your interest in Quaker Houghton and now I'll turn it back over to you Mike.